Docs overprescribe branded drugs: UK report

Share this article:
The UK government says British doctors are overprescribing branded drugs and that pharma marketers are to blame.

One-fifth of general practitioners surveyed said their prescribing behavior was more influenced by pharma marketing than advice from the nation's National Health Service (NHS), according to a Committee of Public Accounts (CPA) study.

The CPA says NHS spends at least $395 million more than it should because UK physicians prescribe higher-cost branded medications rather than cheaper generic versions to their patients.
 “It's hard to doubt that the blandishments of the pharmaceutical industry are having an effect,” said Edward Leigh, chairman of the CPA in a published report.

Meanwhile, a separate report from British Parliament concluded that the NHS doesn't adopt new, branded medications at a quick enough pace.
Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.